380 related articles for article (PubMed ID: 35383784)
1. Network pharmacology combined with metabolomics and lipidomics to reveal the hypolipidemic mechanism of
Yan P; Wei Y; Wang M; Tao J; Ouyang H; Du Z; Li S; Jiang H
Food Funct; 2022 Apr; 13(8):4714-4733. PubMed ID: 35383784
[No Abstract] [Full Text] [Related]
2. Study on mechanism of hepatoprotective effect of Chrysanthemum morifolium Ramat. based on metabolomics with network analysis and network pharmacology.
Yang M; Sun S; Jia X; Wen X; Tian X; Niu Y; Wei J; Jin Y; Du Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1222():123711. PubMed ID: 37059010
[TBL] [Abstract][Full Text] [Related]
3. Serum metabonomics coupled with HPLC-LTQ/orbitrap MS and multivariate data analysis on the ameliorative effects of Bidens bipinnata L. in hyperlipidemic rats.
Wang YQ; Li SJ; Man YH; Zhuang G
J Ethnopharmacol; 2020 Nov; 262():113196. PubMed ID: 32730873
[TBL] [Abstract][Full Text] [Related]
4. Lipidomics of the erythrocyte membrane and network pharmacology to explore the mechanism of mangiferin from Anemarrhenae rhizoma in treating type 2 diabetes mellitus rats.
Zhong Y; Xu Y; Tan Y; Zhang X; Wang R; Chen D; Wang Z; Zhong X
J Pharm Biomed Anal; 2023 Jun; 230():115386. PubMed ID: 37044004
[TBL] [Abstract][Full Text] [Related]
5. Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia.
Zeng B; Qi L; Wu S; Liu N; Wang J; Nie K; Xia L; Yu S
J Vis Exp; 2023 Apr; (194):. PubMed ID: 37092814
[TBL] [Abstract][Full Text] [Related]
6. Hypolipidemic effects of Alismatis rhizome on lipid profile in mice fed high-fat diet.
Dan H; Wu J; Peng M; Hu X; Song C; Zhou Z; Yu S; Fang N
Saudi Med J; 2011 Jul; 32(7):701-7. PubMed ID: 21748207
[TBL] [Abstract][Full Text] [Related]
7. Potential Mechanism of
Ge PY; Qi YY; Qu SY; Zhao X; Ni SJ; Yao ZY; Guo R; Yang NY; Zhang QC; Zhu HX
Drug Des Devel Ther; 2021; 15():1915-1930. PubMed ID: 33976541
[TBL] [Abstract][Full Text] [Related]
8. Urinary biomarker and treatment mechanism of Rhizoma Alismatis on hyperlipidemia.
Miao H; Zhang L; Chen DQ; Chen H; Zhao YY; Ma SC
Biomed Chromatogr; 2017 Apr; 31(4):. PubMed ID: 27571931
[TBL] [Abstract][Full Text] [Related]
9. Systems biology strategy through integrating metabolomics and network pharmacology to reveal the mechanisms of Xiaopi Hewei Capsule improves functional dyspepsia.
Liu R; Li T; Xu H; Yu G; Zhang T; Wang J; Sun Y; Bi Y; Feng X; Wu H; Zhang C; Sun Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jul; 1226():123676. PubMed ID: 37329776
[TBL] [Abstract][Full Text] [Related]
10. The metabolic change of serum lysophosphatidylcholines involved in the lipid lowering effect of triterpenes from Alismatis rhizoma on high-fat diet induced hyperlipidemia mice.
Li S; Jin S; Song C; Chen C; Zhang Y; Xiang Y; Xu Y; Feng Y; Wan Q; Jiang H
J Ethnopharmacol; 2016 Jan; 177():10-8. PubMed ID: 26584875
[TBL] [Abstract][Full Text] [Related]
11. [Anti-colorectal cancer mechanism of Astragali Radix-Curcumae Rhizoma-Paridis Rhizoma based on network pharmacology and experimental verification].
Liang Y; Sun RL; Liu FY; Liu TT; Guan HQ; Tang DC
Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(3):776-785. PubMed ID: 35178961
[TBL] [Abstract][Full Text] [Related]
12. Molecular and metabolic mechanisms of bufalin against lung adenocarcinoma: New and comprehensive evidences from network pharmacology, metabolomics and molecular biology experiment.
Shi S; Zhao S; Tian X; Liu F; Lu X; Zang H; Li F; Xiang L; Li L; Jiang S
Comput Biol Med; 2023 May; 157():106777. PubMed ID: 36924737
[TBL] [Abstract][Full Text] [Related]
13. Integrated metabolomics and network pharmacology to reveal the lipid-lowering mechanisms of Qizha Shuangye granules in hyperlipidemic rats.
Zhao L; Wang S; Xu X; Guo W; Yang J; Liu Y; Xie S; Piao G; Xu T; Wang Y; Xu Y
J Sci Food Agric; 2024 Apr; 104(6):3265-3274. PubMed ID: 38087399
[TBL] [Abstract][Full Text] [Related]
14. Integrated lipidomics and network pharmacology analysis of the protective effects and mechanism of Yuanzhi San on rats with cognitive impairment.
Wang J; Li J; Liu K; Wang S; Su Q; Cheng Y; Wang Y; Wang Y
Bioorg Med Chem; 2022 Mar; 58():116651. PubMed ID: 35176586
[TBL] [Abstract][Full Text] [Related]
15. Integrated Lipidomics and Network Pharmacology Reveal Mechanism of Memory Impairment Improvement by Yuanzhi San.
Zhao F; Li P; Deng F; Wang J; Cheng Y; Pei K; Wang Y; Wang Y
Chem Biodivers; 2023 Mar; 20(3):e202200920. PubMed ID: 36683009
[TBL] [Abstract][Full Text] [Related]
16. Elucidating the mechanisms underlying the anti-hyperlipidemic effects of Laportea bulbifera using integrated serum metabolomics and network pharmacology.
Shi Q; Lin Y; Huang L; Jin S; Huang R; Zhang L; Song C; Xu L; Zhang S
Biomed Chromatogr; 2023 Oct; 37(10):e5707. PubMed ID: 37496197
[TBL] [Abstract][Full Text] [Related]
17. Lei-gong-gen formula granule attenuates hyperlipidemia in rats via cGMP-PKG signaling pathway.
Lan T; Li Q; Chang M; Yin C; Zhu D; Wu Z; Li X; Zhang W; Yue B; Shi J; Yuan H; Su Z; Guo H
J Ethnopharmacol; 2020 Oct; 260():112989. PubMed ID: 32526339
[TBL] [Abstract][Full Text] [Related]
18. Exploration of the Molecular Mechanism of Polygonati Rhizoma in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking.
Zhao J; Lin F; Liang G; Han Y; Xu N; Pan J; Luo M; Yang W; Zeng L
Front Endocrinol (Lausanne); 2021; 12():815891. PubMed ID: 35069454
[TBL] [Abstract][Full Text] [Related]
19. Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia.
Chen Y; Li K; Zhao H; Hao Z; Yang Y; Gao M; Zhao D
J Transl Med; 2022 Sep; 20(1):412. PubMed ID: 36076294
[TBL] [Abstract][Full Text] [Related]
20. Combining metabolomics with network pharmacology to reveal the therapeutic mechanism of Dingchuan Decoction in rats with OVA-induced allergic asthma.
Li Z; Zhao M; Wang Z; Ma L; Pan X; Jin T; Fu Z; Yuan B; Zhao C; Zhang Y
J Pharm Biomed Anal; 2024 Sep; 247():116265. PubMed ID: 38850849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
